BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8364370)

  • 61. Potential new endoscopic techniques for the earlier diagnosis of pre-malignancy.
    Rollins AM; Sivak MV
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):227-47. PubMed ID: 11355913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Endoscopic mucosal resection in the upper and lower GI tract].
    Rösch T
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S126-9. PubMed ID: 15368191
    [No Abstract]   [Full Text] [Related]  

  • 63. [Morphology of N-nitroso-compound induced tumors in the upper digestive tract of rats].
    Thomas C; So BT
    Arzneimittelforschung; 1969 Jul; 19(7):1077-81. PubMed ID: 5394704
    [No Abstract]   [Full Text] [Related]  

  • 64. [Chromoendoscopy vs. Zoomendoscopy].
    Jung M; Hoffman A
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S122-5. PubMed ID: 15368190
    [No Abstract]   [Full Text] [Related]  

  • 65. Improving outcomes in gastrointestinal cancer.
    Alderson D; Winter DC
    Br J Surg; 2013 Jan; 100(1):1-2. PubMed ID: 23169474
    [No Abstract]   [Full Text] [Related]  

  • 66. [High-tech endoscopy and its limits. Utilizing progress but protecting patients from endoscopic undertreatment (interview by Dr. Peter Stiefelhagen)].
    Hagenmüller F
    MMW Fortschr Med; 2005 Feb; 147(6):6. PubMed ID: 15757218
    [No Abstract]   [Full Text] [Related]  

  • 67. Gastrointestinal inherited polyposis syndromes.
    Bronner MP
    Mod Pathol; 2003 Apr; 16(4):359-65. PubMed ID: 12692201
    [No Abstract]   [Full Text] [Related]  

  • 68. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.
    Tateishi K; Ohta M; Kanai F; Guleng B; Tanaka Y; Asaoka Y; Tada M; Seto M; Jazag A; Lianjie L; Okamoto M; Isayama H; Tada M; Yoshida H; Kawabe T; Omata M
    Clin Cancer Res; 2006 Dec; 12(23):6960-6. PubMed ID: 17145814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost and value considerations in screening for oral cancer and precancer.
    Downer MC; Speight PM
    Community Dent Health; 1993 Jun; 10 Suppl 1():71-8. PubMed ID: 8402311
    [No Abstract]   [Full Text] [Related]  

  • 70. Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model.
    Hirose M; Yada H; Hakoi K; Takahashi S; Ito N
    Carcinogenesis; 1993 Nov; 14(11):2359-64. PubMed ID: 8242867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cytological screening of precancer and cancer of the cervix uteri].
    Novik VI
    Vopr Onkol; 1990; 36(12):1411-8. PubMed ID: 2288117
    [No Abstract]   [Full Text] [Related]  

  • 72. The early diagnosis and prevention of oral precancer and cancer.
    Altini M
    J Dent Assoc S Afr; 1989 Mar; Suppl 1():1. PubMed ID: 2623668
    [No Abstract]   [Full Text] [Related]  

  • 73. [Fluorescence endoscopy in gastroenterology].
    Messmann H
    Z Gastroenterol; 2000 Jan; 38(1):21-30. PubMed ID: 10689744
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Precancer biology: importance and possible prevention. Introduction.
    Pontén J
    Cancer Surv; 1998; 32():1-3. PubMed ID: 10489620
    [No Abstract]   [Full Text] [Related]  

  • 75. Proteases in gastrointestinal neoplastic diseases.
    Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Cardin R; Foschia F; Tulassay Z; Naccarato R; Farinati F
    Clin Chim Acta; 2000 Feb; 291(2):171-87. PubMed ID: 10675722
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Precancer: a conceptual working definition -- results of a Consensus Conference.
    Berman JJ; Albores-Saavedra J; Bostwick D; Delellis R; Eble J; Hamilton SR; Hruban RH; Mutter GL; Page D; Rohan T; Travis W; Henson DE
    Cancer Detect Prev; 2006; 30(5):387-94. PubMed ID: 17079091
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The molecular basis of dysplasia.
    Zukerberg L
    Semin Diagn Pathol; 2002 Feb; 19(1):48-53. PubMed ID: 11936266
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening.
    Downer MC; Jullien JA; Speight PM
    Community Dent Health; 1997 Dec; 14(4):227-32. PubMed ID: 9458580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cell biology of precancer.
    Pontén J
    Eur J Cancer; 2001 Oct; 37 Suppl 8():S97-113. PubMed ID: 11602376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Field defects in progression to gastrointestinal tract cancers.
    Bernstein C; Bernstein H; Payne CM; Dvorak K; Garewal H
    Cancer Lett; 2008 Feb; 260(1-2):1-10. PubMed ID: 18164807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.